カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の20Sプロテアソーム市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global 20s Proteasome Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19086）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19086
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の20Sプロテアソーム市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

20Sプロテアソーム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の20Sプロテアソームの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

20Sプロテアソーム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他

用途別セグメントは次のように区分されます。
・大腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他

世界の20Sプロテアソーム市場の主要な市場プレーヤーは以下のとおりです。
・Amgen Inc、Celgene Corp

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、20Sプロテアソーム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な20Sプロテアソームメーカーの企業概要、2019年～2022年までの20Sプロテアソームの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な20Sプロテアソームメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別20Sプロテアソームの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの20Sプロテアソームの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での20Sプロテアソーム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および20Sプロテアソームの産業チェーンを掲載しています。
・第13、14、15章では、20Sプロテアソームの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 20Sプロテアソームの概要
- 種類別分析（2017年vs2021年vs2028年）：マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他
- 用途別分析（2017年vs2021年vs2028年）：大腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他
- 世界の20Sプロテアソーム市場規模・予測
- 世界の20Sプロテアソーム生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Amgen Inc、Celgene Corp
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他
・用途別分析2017年-2028年：大腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他
・20Sプロテアソームの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・20Sプロテアソームのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・20Sプロテアソームのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・20Sプロテアソームの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・20Sプロテアソームの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The 20s Proteasome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global 20s Proteasome market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Colon Cancer accounting for % of the 20s Proteasome global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Marizomib segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of 20s Proteasome include Amgen Inc, Celgene Corp, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
20s Proteasome market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Marizomib
Oprozomib
Carfilzomib
VPEA-002
Others
Market segment by Application can be divided into
Colon Cancer
Lymphoma
Malignant Glioma
Neuroendocrine Cancer
Ovarian Cancer
Others
The key market players for global 20s Proteasome market are listed below:
Amgen Inc
Celgene Corp
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 20s Proteasome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 20s Proteasome, with price, sales, revenue and global market share of 20s Proteasome from 2019 to 2022.
Chapter 3, the 20s Proteasome competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 20s Proteasome breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and 20s Proteasome market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of 20s Proteasome.
Chapter 13, 14, and 15, to describe 20s Proteasome sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 20s Proteasome Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 20s Proteasome Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Marizomib
1.2.3 Oprozomib
1.2.4 Carfilzomib
1.2.5 VPEA-002
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global 20s Proteasome Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Colon Cancer
1.3.3 Lymphoma
1.3.4 Malignant Glioma
1.3.5 Neuroendocrine Cancer
1.3.6 Ovarian Cancer
1.3.7 Others
1.4 Global 20s Proteasome Market Size & Forecast
1.4.1 Global 20s Proteasome Sales in Value (2017 & 2021 & 2028)
1.4.2 Global 20s Proteasome Sales in Volume (2017-2028)
1.4.3 Global 20s Proteasome Price (2017-2028)
1.5 Global 20s Proteasome Production Capacity Analysis
1.5.1 Global 20s Proteasome Total Production Capacity (2017-2028)
1.5.2 Global 20s Proteasome Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 20s Proteasome Market Drivers
1.6.2 20s Proteasome Market Restraints
1.6.3 20s Proteasome Trends Analysis
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business
2.1.3 Amgen Inc 20s Proteasome Product and Services
2.1.4 Amgen Inc 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Celgene Corp
2.2.1 Celgene Corp Details
2.2.2 Celgene Corp Major Business
2.2.3 Celgene Corp 20s Proteasome Product and Services
2.2.4 Celgene Corp 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 20s Proteasome Breakdown Data by Manufacturer
3.1 Global 20s Proteasome Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global 20s Proteasome Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in 20s Proteasome
3.4 Market Concentration Rate
3.4.1 Top 3 20s Proteasome Manufacturer Market Share in 2021
3.4.2 Top 6 20s Proteasome Manufacturer Market Share in 2021
3.5 Global 20s Proteasome Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and 20s Proteasome Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global 20s Proteasome Market Size by Region
4.1.1 Global 20s Proteasome Sales in Volume by Region (2017-2028)
4.1.2 Global 20s Proteasome Revenue by Region (2017-2028)
4.2 North America 20s Proteasome Revenue (2017-2028)
4.3 Europe 20s Proteasome Revenue (2017-2028)
4.4 Asia-Pacific 20s Proteasome Revenue (2017-2028)
4.5 South America 20s Proteasome Revenue (2017-2028)
4.6 Middle East and Africa 20s Proteasome Revenue (2017-2028)
5 Market Segment by Type
5.1 Global 20s Proteasome Sales in Volume by Type (2017-2028)
5.2 Global 20s Proteasome Revenue by Type (2017-2028)
5.3 Global 20s Proteasome Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global 20s Proteasome Sales in Volume by Application (2017-2028)
6.2 Global 20s Proteasome Revenue by Application (2017-2028)
6.3 Global 20s Proteasome Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America 20s Proteasome Sales by Type (2017-2028)
7.2 North America 20s Proteasome Sales by Application (2017-2028)
7.3 North America 20s Proteasome Market Size by Country
7.3.1 North America 20s Proteasome Sales in Volume by Country (2017-2028)
7.3.2 North America 20s Proteasome Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe 20s Proteasome Sales by Type (2017-2028)
8.2 Europe 20s Proteasome Sales by Application (2017-2028)
8.3 Europe 20s Proteasome Market Size by Country
8.3.1 Europe 20s Proteasome Sales in Volume by Country (2017-2028)
8.3.2 Europe 20s Proteasome Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific 20s Proteasome Sales by Type (2017-2028)
9.2 Asia-Pacific 20s Proteasome Sales by Application (2017-2028)
9.3 Asia-Pacific 20s Proteasome Market Size by Region
9.3.1 Asia-Pacific 20s Proteasome Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific 20s Proteasome Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America 20s Proteasome Sales by Type (2017-2028)
10.2 South America 20s Proteasome Sales by Application (2017-2028)
10.3 South America 20s Proteasome Market Size by Country
10.3.1 South America 20s Proteasome Sales in Volume by Country (2017-2028)
10.3.2 South America 20s Proteasome Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa 20s Proteasome Sales by Type (2017-2028)
11.2 Middle East & Africa 20s Proteasome Sales by Application (2017-2028)
11.3 Middle East & Africa 20s Proteasome Market Size by Country
11.3.1 Middle East & Africa 20s Proteasome Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa 20s Proteasome Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of 20s Proteasome and Key Manufacturers
12.2 Manufacturing Costs Percentage of 20s Proteasome
12.3 20s Proteasome Production Process
12.4 20s Proteasome Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 20s Proteasome Typical Distributors
13.3 20s Proteasome Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global 20s Proteasome Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global 20s Proteasome Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Inc Major Business
Table 5. Amgen Inc 20s Proteasome Product and Services
Table 6. Amgen Inc 20s Proteasome Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Celgene Corp Basic Information, Manufacturing Base and Competitors
Table 8. Celgene Corp Major Business
Table 9. Celgene Corp 20s Proteasome Product and Services
Table 10. Celgene Corp 20s Proteasome Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global 20s Proteasome Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 12. Global 20s Proteasome Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in 20s Proteasome, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global 20s Proteasome Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and 20s Proteasome Production Site of Key Manufacturer
Table 16. 20s Proteasome New Entrant and Capacity Expansion Plans
Table 17. 20s Proteasome Mergers & Acquisitions in the Past Five Years
Table 18. Global 20s Proteasome Sales by Region (2017-2022) & (K Pcs)
Table 19. Global 20s Proteasome Sales by Region (2023-2028) & (K Pcs)
Table 20. Global 20s Proteasome Revenue by Region (2017-2022) & (USD Million)
Table 21. Global 20s Proteasome Revenue by Region (2023-2028) & (USD Million)
Table 22. Global 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 23. Global 20s Proteasome Sales by Type (2023-2028) & (K Pcs)
Table 24. Global 20s Proteasome Revenue by Type (2017-2022) & (USD Million)
Table 25. Global 20s Proteasome Revenue by Type (2023-2028) & (USD Million)
Table 26. Global 20s Proteasome Price by Type (2017-2022) & (USD/Pcs)
Table 27. Global 20s Proteasome Price by Type (2023-2028) & (USD/Pcs)
Table 28. Global 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 29. Global 20s Proteasome Sales by Application (2023-2028) & (K Pcs)
Table 30. Global 20s Proteasome Revenue by Application (2017-2022) & (USD Million)
Table 31. Global 20s Proteasome Revenue by Application (2023-2028) & (USD Million)
Table 32. Global 20s Proteasome Price by Application (2017-2022) & (USD/Pcs)
Table 33. Global 20s Proteasome Price by Application (2023-2028) & (USD/Pcs)
Table 34. North America 20s Proteasome Sales by Country (2017-2022) & (K Pcs)
Table 35. North America 20s Proteasome Sales by Country (2023-2028) & (K Pcs)
Table 36. North America 20s Proteasome Revenue by Country (2017-2022) & (USD Million)
Table 37. North America 20s Proteasome Revenue by Country (2023-2028) & (USD Million)
Table 38. North America 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 39. North America 20s Proteasome Sales by Type (2023-2028) & (K Pcs)
Table 40. North America 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 41. North America 20s Proteasome Sales by Application (2023-2028) & (K Pcs)
Table 42. Europe 20s Proteasome Sales by Country (2017-2022) & (K Pcs)
Table 43. Europe 20s Proteasome Sales by Country (2023-2028) & (K Pcs)
Table 44. Europe 20s Proteasome Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe 20s Proteasome Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 47. Europe 20s Proteasome Sales by Type (2023-2028) & (K Pcs)
Table 48. Europe 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 49. Europe 20s Proteasome Sales by Application (2023-2028) & (K Pcs)
Table 50. Asia-Pacific 20s Proteasome Sales by Region (2017-2022) & (K Pcs)
Table 51. Asia-Pacific 20s Proteasome Sales by Region (2023-2028) & (K Pcs)
Table 52. Asia-Pacific 20s Proteasome Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific 20s Proteasome Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 55. Asia-Pacific 20s Proteasome Sales by Type (2023-2028) & (K Pcs)
Table 56. Asia-Pacific 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 57. Asia-Pacific 20s Proteasome Sales by Application (2023-2028) & (K Pcs)
Table 58. South America 20s Proteasome Sales by Country (2017-2022) & (K Pcs)
Table 59. South America 20s Proteasome Sales by Country (2023-2028) & (K Pcs)
Table 60. South America 20s Proteasome Revenue by Country (2017-2022) & (USD Million)
Table 61. South America 20s Proteasome Revenue by Country (2023-2028) & (USD Million)
Table 62. South America 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 63. South America 20s Proteasome Sales by Type (2023-2028) & (K Pcs)
Table 64. South America 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 65. South America 20s Proteasome Sales by Application (2023-2028) & (K Pcs)
Table 66. Middle East & Africa 20s Proteasome Sales by Region (2017-2022) & (K Pcs)
Table 67. Middle East & Africa 20s Proteasome Sales by Region (2023-2028) & (K Pcs)
Table 68. Middle East & Africa 20s Proteasome Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa 20s Proteasome Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa 20s Proteasome Sales by Type (2017-2022) & (K Pcs)
Table 71. Middle East & Africa 20s Proteasome Sales by Type (2023-2028) & (K Pcs)
Table 72. Middle East & Africa 20s Proteasome Sales by Application (2017-2022) & (K Pcs)
Table 73. Middle East & Africa 20s Proteasome Sales by Application (2023-2028) & (K Pcs)
Table 74. 20s Proteasome Raw Material
Table 75. Key Manufacturers of 20s Proteasome Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. 20s Proteasome Typical Distributors
Table 79. 20s Proteasome Typical Customers
List of Figures
Figure 1. 20s Proteasome Picture
Figure 2. Global 20s Proteasome Revenue Market Share by Type in 2021
Figure 3. Marizomib
Figure 4. Oprozomib
Figure 5. Carfilzomib
Figure 6. VPEA-002
Figure 7. Others
Figure 8. Global 20s Proteasome Revenue Market Share by Application in 2021
Figure 9. Colon Cancer
Figure 10. Lymphoma
Figure 11. Malignant Glioma
Figure 12. Neuroendocrine Cancer
Figure 13. Ovarian Cancer
Figure 14. Others
Figure 15. Global 20s Proteasome Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 16. Global 20s Proteasome Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global 20s Proteasome Sales (2017-2028) & (K Pcs)
Figure 18. Global 20s Proteasome Price (2017-2028) & (USD/Pcs)
Figure 19. Global 20s Proteasome Production Capacity (2017-2028) & (K Pcs)
Figure 20. Global 20s Proteasome Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. 20s Proteasome Market Drivers
Figure 22. 20s Proteasome Market Restraints
Figure 23. 20s Proteasome Market Trends
Figure 24. Global 20s Proteasome Sales Market Share by Manufacturer in 2021
Figure 25. Global 20s Proteasome Revenue Market Share by Manufacturer in 2021
Figure 26. 20s Proteasome Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 20s Proteasome Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 20s Proteasome Manufacturer (Revenue) Market Share in 2021
Figure 29. Global 20s Proteasome Sales Market Share by Region (2017-2028)
Figure 30. Global 20s Proteasome Revenue Market Share by Region (2017-2028)
Figure 31. North America 20s Proteasome Revenue (2017-2028) & (USD Million)
Figure 32. Europe 20s Proteasome Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific 20s Proteasome Revenue (2017-2028) & (USD Million)
Figure 34. South America 20s Proteasome Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa 20s Proteasome Revenue (2017-2028) & (USD Million)
Figure 36. Global 20s Proteasome Sales Market Share by Type (2017-2028)
Figure 37. Global 20s Proteasome Revenue Market Share by Type (2017-2028)
Figure 38. Global 20s Proteasome Price by Type (2017-2028) & (USD/Pcs)
Figure 39. Global 20s Proteasome Sales Market Share by Application (2017-2028)
Figure 40. Global 20s Proteasome Revenue Market Share by Application (2017-2028)
Figure 41. Global 20s Proteasome Price by Application (2017-2028) & (USD/Pcs)
Figure 42. North America 20s Proteasome Sales Market Share by Type (2017-2028)
Figure 43. North America 20s Proteasome Sales Market Share by Application (2017-2028)
Figure 44. North America 20s Proteasome Sales Market Share by Country (2017-2028)
Figure 45. North America 20s Proteasome Revenue Market Share by Country (2017-2028)
Figure 46. United States 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe 20s Proteasome Sales Market Share by Type (2017-2028)
Figure 50. Europe 20s Proteasome Sales Market Share by Application (2017-2028)
Figure 51. Europe 20s Proteasome Sales Market Share by Country (2017-2028)
Figure 52. Europe 20s Proteasome Revenue Market Share by Country (2017-2028)
Figure 53. Germany 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific 20s Proteasome Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific 20s Proteasome Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific 20s Proteasome Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific 20s Proteasome Revenue Market Share by Region (2017-2028)
Figure 62. China 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America 20s Proteasome Sales Market Share by Type (2017-2028)
Figure 69. South America 20s Proteasome Sales Market Share by Application (2017-2028)
Figure 70. South America 20s Proteasome Sales Market Share by Country (2017-2028)
Figure 71. South America 20s Proteasome Revenue Market Share by Country (2017-2028)
Figure 72. Brazil 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa 20s Proteasome Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa 20s Proteasome Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa 20s Proteasome Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa 20s Proteasome Revenue Market Share by Region (2017-2028)
Figure 78. Turkey 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa 20s Proteasome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of 20s Proteasome in 2021
Figure 83. Manufacturing Process Analysis of 20s Proteasome
Figure 84. 20s Proteasome Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の血漿分画装置市場2022年：市場規模予測（～2028年）
  • 世界のヒト肝臓モデル市場2022年：市場規模予測（～2028年）
  • 世界のハイブリッド手首固定器市場2022年：市場規模予測（～2028年）
  • 世界の手術器具用保持アーム市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19086 )"世界の20Sプロテアソーム市場2022年：市場規模予測（～2028年）" (英文：Global 20s Proteasome Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。